Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex (Journal of Biomedical Science, (2015), 22, 1, (4), 10.1186/s12929-014-0108-9);EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex

Journal of Biomedical Science

Volumn 22, Issue 1, 2015, Pages

  Subramanian, Nithya ^a,b   Kanwar, Jagat R ^b   Athalya, Prasanna Kumar ^a,b   Janakiraman, Narayanan ^a   Khetan, Vikas ^c   Kanwar, Rupinder K ^b   Eluchuri, Sailaja ^a   Krishnakumar, Subramanian ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b DEAKIN UNIVERSITY   (Australia)

^c MEDICAL RESEARCH FOUNDATION   (India)

Author keywords

Aptamer; Cancer targeting; EpCAM; PEI EpApt SiEp; siRNA delivery

Indexed keywords

ANTINEOPLASTIC AGENT; EPITHELIAL CELL ADHESION MOLECULE; EPITHELIAL CELL ADHESION MOLECULE APTAMER; EPITHELIAL CELL ADHESION MOLECULE SMALL INTERFERING RNA; NANOCARRIER; PEPTIDE APTAMER; POLYETHYLENEIMINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; APTAMER; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; NANOMATERIAL; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; COMPARATIVE STUDY; COMPLEX FORMATION; CYTOTOXICITY; DOWN REGULATION; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; GENE TARGETING; HUMAN; LIGHT SCATTERING; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA; SURFACE CHARGE; WESTERN BLOTTING; ZETA POTENTIAL; CHEMISTRY; DRUG EFFECTS; FEMALE; MCF-7 CELL LINE; METABOLISM; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; APTAMERS, NUCLEOTIDE; BIOMARKERS, TUMOR; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL CELL ADHESION MOLECULE; FEMALE; HUMANS; MCF-7 CELLS; NANOSTRUCTURES; POLYETHYLENEIMINE; RNA, SMALL INTERFERING;

EID: 84927713763     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/s12929-020-00687-2     Document Type: Erratum

References (39)

1. Munz M, Baeuerle PA, Gires O. The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 2009;69:5627-9.
2. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004;64:5818-24.
3. Sithambaram D, Palanivelu S, Subramanian K, Sahoo S, Verma RS. Specific targeting of Ep-CAM in various carcinomas by novel monoclonal antibodies. Hybridoma. 2011;30:511-8.
4. Winkler J, Martin-Killias P, Pluckthun A, Zangemeister-Wittke U. EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins. Mol Cancer Ther. 2009;8:2674-83.
5. Shigdar S, Lin J, Yu Y, Pastuovic M, Wei M, Duan W. RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule. Cancer Sci. 2011;102:991-8.
6. Song Y, Zhu Z, An Y, Zhang W, Zhang H, Liu D, et al. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture. Anal Chem. 2013;85:4141-9.
7. Kanwar JR, Roy K, Kanwar RK. Chimeric aptamers in cancer cell-targeted drug delivery. Crit Rev Biochem Mol Biol. 2011;46:459-77.
8. Subramanian N, Raghunathan V, Kanwar JR, Kanwar RK, Elchuri SV, Khetan V, et al. Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer. Mol Vis. 2012;18:2783-95.
9. Li L, Xiang D, Shigdar S, Yang W, Li Q, Lin J, et al. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells. Int J Nanomedicine. 2014;9:1083-96.
10. Kim DH, Rossi JJ. Strategies for silencing human disease using RNA interference. Nat Rev Genet. 2007;8:173-84.
11. Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, Alabi CA, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature. 2010;464:1067-70.
12. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009;8:129-38.
13. Kwiatt ME, Patel MS, Ross SE, Lachant MT, MacNew HG, Ochsner MG, et al. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study. J Trauma Acute Care Surg. 2012;73:625-8.
14. Luten J, van Nostrum CF, De Smedt SC, Hennink WE. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J Control Release. 2008;126:97-110.
15. El-Andaloussi S, Lee Y, Lakhal-Littleton S, Li J, Seow Y, Gardiner C, et al. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc. 2012;7:2112-26.
16. Subramanian N, Mani P, Roy S, Gnanasundram SV, Sarkar DP, Das S. Targeted delivery of hepatitis C virus-specific short hairpin RNA in mouse liver using Sendai virosomes. J Gen Virol. 2009;90:1812-9.
17. van den Boorn JG, Schlee M, Coch C, Hartmann G. SiRNA delivery with exosome nanoparticles. Nat Biotechnol. 2011;29:325-6.
18. Kim WJ, Kim SW. Efficient siRNA delivery with non-viral polymeric vehicles. Pharm Res. 2009;26:657-66.
19. Wang J, Dou B, Bao Y. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier. Mater Sci Eng C Mater Biol Appl. 2014;34:98-109.
20. Grayson AC, Doody AM, Putnam D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm Res. 2006;23:1868-76.
21. Mady M, Mohammed W, El-Guendy NM, Elsayed A. Effect of polymer molecular weight on the DNA/PEI polyplexes properties. Rom J Biophys. 2011;21:151-65.
22. Slita AV, Kasyanenko NA, Nazarova OV, Gavrilova II, Eropkina EM, Sirotkin AK, et al. DNA-polycation complexes: effect of polycation structure on physico-chemical and biological properties. J Biotechnol. 2007;127:679-93.
23. Beyerle A, Long AS, White PA, Kissel T, Stoeger T. Poly(ethylene imine) nanocarriers do not induce mutations nor oxidative DNA damage in vitro in MutaMouse FE1 cells. Mol Pharm. 2011;8:976-81.
24. Bonnet M-E, Erbacher P, Bolcato-Bellemin A-L. Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response. Pharm Res. 2008;25:2972-82.
25. Hao H, Zhen Y, Wang Z, Chen F, Xie X. A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA. Cell Biol Int. 2013;37:860-4.
26. Simon M, Stefan N, Pluckthun A, Zangemeister-Wittke U. Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy. Expert Opin Drug Deliv. 2013;10:451-68.
27. Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol. 2005;23:709-17.
28. Mitra M, Kandalam M, Rangasamy J, Shankar B, Maheswari UK, Swaminathan S, et al. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells. Mol Vis. 2013;19:1029-38.
29. Zhao N, Bagaria HG, Wong MS, Zu Y. A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma. J Nanobiotechnol. 2011;9:2.
30. Gao Y, Liu XL, Li XR. Research progress on siRNA delivery with nonviral carriers. Int J Nanomedicine. 2011;6:1017-25.
31. Lu H, Wang D, Kazane S, Javahishvili T, Tian F, Song F, et al. Site-specific antibody-polymer conjugates for siRNA delivery. J Am Chem Soc. 2013;135:13885-91.
32. Miele E, Spinelli GP, Miele E, Di Fabrizio E, Ferretti E, Tomao S, et al. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy. Int J Nanomedicine. 2012;7:3637-57.
33. Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 2005;12:461-6.
34. Bagalkot V, Gao X. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing. ACS Nano. 2011;5:8131-9.
35. Shahidi-Hamedani N, Shier WT, Moghadam Ariaee F, Abnous K, Ramezani M. Targeted gene delivery with noncovalent electrostatic conjugates of sgc-8c aptamer and polyethylenimine. J Gene Med. 2013;15:261-9.
36. Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small. 2009;5:1408-13.
37. Clift MJ, Bhattacharjee S, Brown DM, Stone V. The effects of serum on the toxicity of manufactured nanoparticles. Toxicol Lett. 2010;198:358-65.
38. Patnaik S, Gupta KC. Novel polyethylenimine-derived nanoparticles for in vivo gene delivery. Expert Opin Drug Deliv. 2013;10:215-28.
39. Amjad MW, Amin MC, Katas H, Butt AM. Doxorubicin-loaded cholic acid-polyethyleneimine micelles for targeted delivery of antitumor drugs: synthesis, characterization, and evaluation of their in vitro cytotoxicity. Nanoscale Res Lett. 2012;7:687.